Redefine Surgery Closes Oversubscribed Pre-Seed Round and Announces Catalyst OrthoScience Partnership
Redefine Surgery, a medical technology company building physical AI for surgery, today announced the closing of an oversubscribed pre-seed financing round, bringing total capital raised to $10 million. Backed predominantly by surgeon investors, the financing will support continued development of the company’s surgical intelligence platform as it advances toward commercialization.
